Is there any difference between imported and domestically produced Baricitinib?

Baricitinib (Baricitinib) is a drug, whether it is imported or domestically produced, its drug ingredients and mechanism of action are the same. The core chemical structure of baricitinib is the same whether it is produced imported or domestically.

Imported baricitinib is produced by foreign manufacturers, while domestic baricitinib is produced by domestic manufacturers. Different manufacturers may have different production processes and quality control standards. Imported drugs generally need to comply with local regulatory agency requirements, while domestically produced drugs need to comply with domestic regulatory agency requirements.

The supply chain for imported drugs may differ from that for domestic drugs. Imported drugs may be affected by factors such as international trade, customs and logistics, so the reliability and stability of supply may vary. Domestic drugs may be more accessible and have a more stable supply.

Imported drugs often involve additional import costs and duties, so their prices may be relatively high. Domestic drugs may be more competitive in price and more likely to be covered by insurance.

Baricitinib has been launched in China and is included in medical insurance. Patients can purchase it domestically. Due to different medical insurance reimbursement policies in different regions, the reimbursement ratio is also different. The price is about 1200~1600 yuan. For specific prices, please consult the local pharmacy or the medical insurance bureau. Baricitinib has both original and generic drugs abroad. The original drug is mainly Eli Lilly’s original drug, and its price is higher than in China. Generic drugs are mainly Bangladeshi generic drugs, and the price is around 450 yuan. The ingredients of original drugs and generic drugs are basically the same.